Activin type 2B receptor Fc fusion protein STM 434

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

A soluble fusion protein containing the extracellular domain of the activin receptor type 2B (ACVR2B or ActRIIB) fused to a human Fc domain, with potential antineoplastic activity. Upon intravenous administration, STM 434 selectively binds to the growth factor activin A, thereby preventing its binding to and the activation of endogenous ActRIIB. This prevents activin A/ActRIIB-mediated signaling and inhibits the proliferation of activin A-overexpressing tumor cells. Activin A, a member of the transforming growth factor beta (TGF-beta) superfamily, is overexpressed in a variety of cancers and plays a key role in promoting cancer cell proliferation, migration, and survival.

Learn more about Activin type 2B receptor Fc fusion protein STM 434

Latest research - Activin type 2B receptor Fc fusion protein STM 434

PubMed
Clinical trials

External links

Wikipedia
Medicine icon
Medicine icon

This WikiMD article Activin type 2B receptor Fc fusion protein STM 434 is a stub. If you are familiar with the topic Activin type 2B receptor Fc fusion protein STM 434, you can help us. Paid editors welcome!

 

Activin type 2B receptor Fc fusion protein STM 434 is part of WikiMD's free ^articles!

^Activin type 2B receptor Fc fusion protein STM 434 (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available